MedRhythms - About the company
MedRhythms is a series B company based in Boston (United States), founded in 2013 by Brian Harris and Owen Mccarthy. It operates as a Provider of wearable devices to combat neurological injuries and recover walking functions. MedRhythms has raised $64.2M in funding from Morningside and Advantage Capital. The company has 214 active competitors, including 53 funded and 12 that have exited. Its top competitors include companies like Insulet, Ceribell and HyperIce.
Company Details
Provider of wearable devices to combat neurological injuries and recover walking functions. The company has developed inertial measurement unit (IMU) sensors to measure gait parameters and run proprietary algorithms on them to make changes to the music accordingly. It uses artificial intelligence to personalize and improve the algorithm over time, as well as make predictive insights about the user population.
- Website
- medrhythms.com
- Email ID
- *****@medrhythms.com
- Registered Address
- Portland, Maine
Key Metrics
Founded Year
2013
Location
Boston, United States
Stage
Series B
Total Funding
$64.2M in 8 rounds
Latest Funding Round
Investors
Ranked
13th among 214 active competitors
Employee Count
52 as on Sep 30, 2026
Legal entities associated with MedRhythms
MedRhythms is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Medrhythms, Inc. CIN: 474668808 , United States, Active | Dec 31, 2012 | - | 34 (As on Dec 31, 2024) | - |
MedRhythms Inc CIN: 5795485 , United States, Active | - | 8 (As on Dec 31, 2018) | - |
Sign up to download MedRhythms' company profile
MedRhythms's funding and investors
MedRhythms has raised a total funding of $64.2M over 8 rounds. Its first funding round was on Jun 29, 2018. MedRhythms has 10 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of MedRhythms:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 31, 2026 | 8185268 | Series B | 7323565 | 1040814 | 5117809 | 3423023 |
Feb 13, 2026 | 8427850 | Series B | 7989651 | 9164876 | 9556527 | 6394710 |
Mar 28, 2025 | 3972529 | Series B | 2892337 | 5580909 | 6123763 | 7202306 |
View details of MedRhythms's funding rounds and investors
MedRhythms' founders and board of directors
Founder? Claim ProfileThe founders of MedRhythms are Brian Harris and Owen Mccarthy. Brian Harris is the CEO of MedRhythms.
Here are the details of MedRhythms' key team members:
- Brian Harris: Co-Founder & CEO of MedRhythms. Contact Info: 1 email address
- Owen Mccarthy: Co-Founder of MedRhythms. Contact Info: 1 email address
View details of MedRhythms's Founder profiles and Board Members
MedRhythms' employee count trend
MedRhythms has 52 employees as of Sep 26. Here is MedRhythms's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
MedRhythms's Competitors and alternates
Top competitors of MedRhythms include Insulet, Ceribell and HyperIce. Here is the list of Top 10 competitors of MedRhythms, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Insulet 2000, Boston (United States), Public | Manufacturer of wearable, tubeless insulin delivery systems for diabetes management | $120M | 74/100 | |
2nd | Ceribell 2014, Mountain View (United States), Public | EEG system for the diagnosis of seizures | $188M | 69/100 | |
3rd | HyperIce 2011, Irvine (United States), Series C | Internet first brand offering smart devices for physical fitness | $52.5M | 69/100 | |
4th | Athelas 2014, Mountain View (United States), Series A | Provider of smart solutions for monitoring heart rate, weight, and blood pressure | $136M | 61/100 | |
5th | Mainstay Medical 2008, Dublin (Ireland), Public | Provider of rehabilitation solutions for patients and doctors | $27.2M | 60/100 | |
6th | Sava 2021, London (United Kingdom), Series A | Developer of minimally invasive, multi-molecule biosensors for continuous health monitoring | $38.5M | 56/100 | |
7th | KT Tape 2009, American Fork (United States), Acquired | Manufacturer of kinesiology tape, health products, and related application accessories | - | 56/100 | |
8th | Wearable Robotics 2014, Pisa (Italy), Series A | Exoskeletons and robotic rehabilitation devices | $8.51M | 53/100 | |
9th | Startoon Labs 2017, Secunderabad (India), Seed | Developer of medical device for physiotherapy assessment, monitoring, and reporting | $465K | 52/100 | |
10th | Flint Rehab 2011, Irvine (United States), Early Stage | Developer of stroke rehabilitation systems | $8M | 52/100 | |
13th | MedRhythms 2013, Boston (United States), Series B | Provider of wearable devices to combat neurological injuries and recover walking functions | $64.2M | 51/100 |
Looking for more details on MedRhythms's competitors? Click here to see the top ones
MedRhythms's Investments and acquisitions
MedRhythms has made no investments or acquisitions yet.
Reports related to MedRhythms
Here is the latest report on MedRhythms's sector:
News related to MedRhythms
•
MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson's DiseasePR Newswire•Mar 06, 2025•MedRhythms
•
•
MedRhythms Announces New CMS Reimbursement Code for InTandem® Rehabilitation System For Chronic Stroke Gait ImpairmentPR Newswire•Aug 22, 2024•MedRhythms
•
MedRhythms Announces Key Publications Confirming Efficacy, Safety, and Usability of InTandem™ for Chronic Stroke Walking ImpairmentPR Newswire•Feb 08, 2024•MedRhythms
•
MedRhythms Selects Curavit as its Contract Research Organization (CRO) for a Chronic Stroke Decentralized Clinical TrialTullahoma News•Sep 21, 2023•MedRhythms, Curavit
•
Medrhythms Has Filed A Notice Of An Exempt Offering Of Securities To Raise $8,000,000.00 In New Debt Financing.intelligence360•Mar 02, 2023•MedRhythms
•
•
•
MedRhythms Announces Addition of Global Brain Corporation and Bose Ventures to Series B RoundBusiness Wire•Nov 16, 2021•MedRhythms, Global Brain, Bose Ventures
•
Are you a Founder ?
FAQs about MedRhythms
Explore our recently published companies
- Benexit - Boise based, 2014 founded, Unfunded company
- SAMIRA Creative - United States based, 2020 founded, Unfunded company
- Lamouroux - Beychac-et-Caillau based, 1988 founded, Acquired company
- Sacyr - Unfunded company
- Corinne Mah - Unfunded company
- Netcom Associates - India based, 2002 founded, Unfunded company
